Cleared Traditional

K062589 - SERENITY PSF (PNEUMATIC SKIN FLATTENING) SYSTEM

K062589 is an FDA 510(k) clearance for SERENITY PSF (PNEUMATIC SKIN FLATTENING..., manufactured by Inolase 2002, Ltd.. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K062589 · Inolase 2002, Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2006
Decision
90d
Days
Class 2
Risk

K062589 is an FDA 510(k) clearance for the SERENITY PSF (PNEUMATIC SKIN FLATTENING) SYSTEM. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Inolase 2002, Ltd. (Somerset, US). The FDA issued a Cleared decision on November 30, 2006 after a review of 90 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Inolase 2002, Ltd. devices

FDA 510(k) Submission Details - K062589

510(k) Number K062589 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 01, 2006
Decision Date November 30, 2006
Days to Decision 90 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 115d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 1918
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K062589.
CANDELA FAMILY OF Q-SWITCHED ALEXANDRITE LASER (ALEXLAZR) SYSTEMS
K063073 · Candela Corp. · Dec 2006
PALOMAR Q-YAG 5 ND:YAG LASER SYSTEM
K061436 · Palomar Medical Technologies, Inc. · Dec 2006
GREENLIGHT HPS SERIES SURGICAL LASER SYSTEM & ACCESSORIES
K062719 · Laserscope · Dec 2006
VARI-LASE ENDOVENOUS LASER CONSOLE, MODEL 7500
K062822 · Vascular Solutions, Inc. · Nov 2006
DENLASER 800 PLUS
K062619 · CAO Group, Inc. · Nov 2006
SMARTLIPO ND:YAG LASER
K062321 · Cynosure, Inc. · Oct 2006